Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Rheumatology"
DOI: 10.1007/s10067-021-05757-w
Abstract: The prevalence of sarcopenia with osteoporosis results in a higher risk of falling and fractures. It was noted that patients who had completed their planned 5-year denosumab therapy course as treatment for these conditions started… read more here.
Keywords: falls risk; denosumab; osteoporosis; sarcopenia measures ... See more keywords